- Home
- MIRA vs TKLF Comparison
MIRA vs TKLF Comparison
Compare MIRA & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- TKLF
- Stock Information
- Founded
- MIRA 2020
- TKLF 2006
- Country
- MIRA United States
- TKLF Japan
- Employees
- MIRA 6
- TKLF N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- TKLF Other Specialty Stores
- Sector
- MIRA Health Care
- TKLF Consumer Discretionary
- Exchange
- MIRA Nasdaq
- TKLF Nasdaq
- Market Cap
- MIRA 17.4M
- TKLF 18.5M
- IPO Year
- MIRA 2023
- TKLF 2022
- Fundamental
- Price
- MIRA $1.09
- TKLF $3.47
- Analyst Decision
- MIRA Strong Buy
- TKLF
- Analyst Count
- MIRA 2
- TKLF 0
- Target Price
- MIRA $14.00
- TKLF N/A
- AVG Volume (30 Days)
- MIRA 493.9K
- TKLF 45.4K
- Earning Date
- MIRA 11-12-2024
- TKLF 12-18-2024
- Dividend Yield
- MIRA N/A
- TKLF N/A
- EPS Growth
- MIRA N/A
- TKLF N/A
- EPS
- MIRA N/A
- TKLF 2.01
- Revenue
- MIRA N/A
- TKLF $195,681,315.00
- Revenue This Year
- MIRA N/A
- TKLF N/A
- Revenue Next Year
- MIRA N/A
- TKLF N/A
- P/E Ratio
- MIRA N/A
- TKLF $1.85
- Revenue Growth
- MIRA N/A
- TKLF 15.29
- 52 Week Low
- MIRA $0.51
- TKLF $2.00
- 52 Week High
- MIRA $5.01
- TKLF $10.00
- Technical
- Relative Strength Index (RSI)
- MIRA 37.31
- TKLF 44.96
- Support Level
- MIRA $1.04
- TKLF $3.54
- Resistance Level
- MIRA $1.16
- TKLF $3.95
- Average True Range (ATR)
- MIRA 0.10
- TKLF 0.30
- MACD
- MIRA -0.02
- TKLF 0.07
- Stochastic Oscillator
- MIRA 24.29
- TKLF 40.45
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About TKLF Yoshitsu Co. Ltd
Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.